Latest News
|
19 February 2013
0 Likes 
Provita Pharmaceuticals isn’t your average life sciences research and development company. Based out of New Jersey, it doesn’t have its own multimillion-dollar research facilities or even much
Read More...
Latest News
|
3 December 2012
0 Likes
The European Medicines Agency (EMA) has released a new guideline to instruct sponsors of clinical trials on best practices for assessing antibody-based products used to prevent the hepatitis B
Read More...
Latest News
|
12 November 2012
0 Likes
Italy's Agenxia Italiana del Farmaco (AIFA) has joined Canadian and Swiss regulators in affirming the safety of Novartis' Agrippal (alternately known as Agriflu) and Fluad after concerns were raised
Read More...
Latest News
|
5 November 2012
0 Likes
Regulators with Health Canada and Switzerland's Swissmedic are lifting their respective bans on Novartis' trivalent flu vaccines Agrippal and Fluad after independent testing found them to be safe for
Read More...
Latest News
|
29 October 2012
0 Likes
Three more regulatory agencies have called for the recall and cessation of sales of two influenza vaccines manufactured by Novartis after the company reported finding particulate matter during its
Read More...
Latest News
|
26 October 2012
0 Likes
Two influenza vaccines manufactured by Novartis, a Swiss pharmaceutical company, have seen their marketing privileges temporarily revoked in at least three European countries this week as regulators
Read More...
Latest News
|
9 October 2012
0 Likes
UK regulators with the Medicines and Healthcare products Regulatory Agency (MHRA) have issued a drug alert to healthcare practitioners warning them of a recall involving Sanofi Pasteur MSD's typhoid
Read More...
Latest News
|
27 July 2012
0 Likes
The US Food and Drug Administration (FDA) is widely known as the country’s chief federal regulator of biological products. Lesser-known—but still important—is another federal program known as the
Read More...
Latest News
|
15 June 2012
0 Likes
A new combination vaccine that protects infants against meningococcal disease and Hib disease received approval from the US Food and Drug Administration (FDA) on 14 June, the agency said.Reuters
Read More...
Latest News
|
3 May 2012
0 Likes
The US Food and Drug Administration’s (FDA) Center for Biologics Evaluation and Research (CBER) is announcing its intent to launch a program to ensure the safety of vaccine products manufactured
Read More...